Tech Company Financing Transactions
Lys Therapeutics Funding Round
On 6/23/2026, Lys Therapeutics raised $28 million in funding from Bpifrance, The Michael J. Fox Foundation for Parkinson's Research and private investors.
Transaction Overview
Company Name
Announced On
6/23/2026
Transaction Type
Debt
Venture Equity
Venture Equity
Amount
$28,000,000
Round
Undisclosed
Proceeds Purpose
The company intends to use the funds to complete regulatory studies, ensure manufacturing readiness, and finance the clinical entry of its lead asset through a biomarker-rich Phase 1a/1b testing program.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
56 rue Saint-Jean-De-Dieu
LYON, 69007
France
LYON, 69007
France
Phone
Undisclosed
Website
Email Address
Not Recorded
Overview
Lys Therapeutics, first-in-class biotherapies for neurological diseases. Lys Therapeutics' main drug-candidate, LYS241, is a first-in-class monoclonal antibody displaying a groundbreaking mechanism of action counteracting these mechanisms by specifically preventing inside blood vessels the binding of tPA on NMDA receptors, without blocking the physiological function of NMDAr.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chairman
Michel Vounatsos
Chief Executive Officer
Manuel Blanc
Chief Financial Officer
Philippe Dujardin
Chief Operating Officer
Jean-Baptiste Bertrand
Chief Operating Officer
Jordan Guyon
Chief Scientific Officer
Denis Vivien
Chief Technical Officer
Werner Klinger
VP - Bus. Development
Riad Abes
Browse more venture capital transactions:
Prev: 6/23/2026: Probook venture capital transaction
Next: 6/23/2026: Versework venture capital transaction
Share this article
Where The Data Comes From
We do our best to document every notable VC transaction. VC investment data records on this site are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs